Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis, Rheumatology, vol.43, issue.7, pp.906-914, 2004. ,
DOI : 10.1093/rheumatology/keh199
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis, Arthritis & Rheumatism, vol.143, issue.3, pp.315-324, 1988. ,
DOI : 10.1002/art.1780310302
Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value, Arthritis Research, vol.4, issue.2, pp.87-93, 2002. ,
DOI : 10.1186/ar395
Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors, Arthritis & Rheumatism, vol.44, issue.2, pp.380-386, 2004. ,
DOI : 10.1002/art.20018
Autoantibodies recognizing citrullinated rat filaggrin in an ELISA using citrullinated and non-citrullinated recombinant proteins as antigens are highly diagnostic for rheumatoid arthritis, Clinical and Experimental Immunology, vol.62, issue.1, pp.173-180, 2004. ,
DOI : 10.1002/art.10229
Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis, J Rheumatol, vol.29, pp.2074-2076, 2002. ,
The shared epitope hypothesis. an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis, Arthritis & Rheumatism, vol.4, issue.11, pp.1205-1213, 1987. ,
DOI : 10.1002/art.1780301102
Quantifying the exact role of HLA-DRB1 alleles in susceptibility to inflammatory polyarthritis: Results from a large, population-based study, Arthritis & Rheumatism, vol.39, issue.4, pp.757-762, 1999. ,
DOI : 10.1002/1529-0131(199904)42:4<757::AID-ANR20>3.0.CO;2-X
The genetics revolution and the assault on rheumatoid arthritis, Arthritis & Rheumatism, vol.18, issue.Suppl 9, pp.1071-1079, 1999. ,
DOI : 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8
New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study, Proceedings of the National Academy of Sciences, vol.6, issue.7, pp.10746-10750, 1998. ,
DOI : 10.1093/hmg/6.7.1003
Identification of the gene loci that predispose to rheumatoid arthritis., International Immunology, vol.10, issue.12, pp.1891-1895, 1998. ,
DOI : 10.1093/intimm/10.12.1891
The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2?p36.3, Human Genetics, vol.87, issue.5, pp.623-624, 1991. ,
DOI : 10.1007/BF00209026
Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians, Arthritis & Rheumatism, vol.43, issue.1, pp.61-65, 2001. ,
DOI : 10.1002/1529-0131(200101)44:1<61::AID-ANR9>3.0.CO;2-Q
Association between tumor necrosis factor receptor II and familial, but not sporadic, rheumatoid arthritis: Evidence for genetic heterogeneity, Arthritis & Rheumatism, vol.43, issue.Suppl 9, pp.2039-2044, 2002. ,
DOI : 10.1002/art.10101
TNFR2 position 196 polymorphism in Japanese patients with rheumatoid arthritis: Comment on the article by Dieud?? et al, Arthritis & Rheumatism, vol.48, issue.1, pp.273-274, 2003. ,
DOI : 10.1002/art.10600
Tumor necrosis factor receptor type II (exon 6) and interleukin-6 (???174) gene polymorphisms are not associated with family history but tumor necrosis factor receptor type II is associated with hypertension in patients with rheumatoid arthritis from northe, Arthritis & Rheumatism, vol.26, issue.Suppl 9, pp.3096-3098, 2002. ,
DOI : 10.1002/art.10592
Tumor necrosis factor receptor II gene polymorphism and severity of rheumatoid arthritis, Arthritis & Rheumatism, vol.39, issue.3, pp.742-747, 2004. ,
DOI : 10.1002/art.20113
No association of polymorphisms in the tumor necrosis factor receptor I and receptor II genes with disease severity in rheumatoid arthritis, J Rheumatol, vol.30, pp.1406-1409, 2003. ,
No association between tumour necrosis factor receptor type 2 gene polymorphism and rheumatoid arthritis severity: a comparison of the extremes of phenotypes, Rheumatology, vol.43, issue.10, pp.1232-1234, 2004. ,
DOI : 10.1093/rheumatology/keh314
Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score., Annals of the Rheumatic Diseases, vol.49, issue.11, pp.916-920, 1990. ,
DOI : 10.1136/ard.49.11.916
Association of tumor necrosis factor receptor type II polymorphism 196R with systemic lupus erythematosus in the Japanese: Molecular and functional analysis, Arthritis & Rheumatism, vol.334, issue.12, pp.2819-2827, 2001. ,
DOI : 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2
A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA- DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis, Arthritis Research & Therapy, vol.6, issue.4, pp.303-308, 2004. ,
DOI : 10.1186/ar1187
Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis, Annals of the Rheumatic Diseases, vol.63, issue.3, pp.274-279, 2004. ,
DOI : 10.1136/ard.2003.010298
Early and aggressive treatment of rheumatoid arthritis patients affects the association of HLA class II antigens with progression of joint damage, Arthritis & Rheumatism, vol.46, issue.4, pp.899-905, 2002. ,
DOI : 10.1002/art.10151
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: A multicenter, double-blind, placebo-controlled trial, Arthritis & Rheumatism, vol.39, issue.6, pp.1761-1769, 2004. ,
DOI : 10.1002/art.20303
The Met-196 -> Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-??-induced Apoptosis by Impaired NF-??B Signaling and Target Gene Expression, Journal of Biological Chemistry, vol.280, issue.7, pp.5994-6004, 2005. ,
DOI : 10.1074/jbc.M411541200
Tumor necrosis factor-alpha receptor II polymorphism in patients from southern Europe with mild-moderate and severe rheumatoid arthritis, J Rheumatol, vol.29, pp.1847-1850, 2002. ,